Stay updated on Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page; its footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:31:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A 403 Forbidden error now displays on the study page, replacing the former content with an error screen. This blocks access to the study details and related information.
    Difference
    18%
    Check dated 2026-09-21T22:25:51.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The site revision indicator was updated from Revision: v3.6.5 to Revision: v3.6.6, signaling a deployment or update to the page. This change does not alter the study content or how the page presents information to users.
    Difference
    0.1%
    Check dated 2026-08-31T17:50:52.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now shows a new revision number (v3.6.5) replacing the previous revision (v3.6.4). This is a minor maintenance update and does not modify study data or displayed details.
    Difference
    0.0%
    Check dated 2026-08-10T13:31:29.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, indicating a new build of the site's template. The change reflects internal updates to the page framework and does not modify the trial details shown to users.
    Difference
    0.0%
    Check dated 2026-07-27T05:45:26.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the study page, likely due to editorial or QC updates.
    Difference
    0.0%
    Check dated 2026-07-05T11:17:13.000Z thumbnail image

Stay in the know with updates to Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.